Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have been assigned an average recommendation of “Hold” from the sixteen brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $7.5357.

A number of analysts recently commented on the stock. Citigroup lowered their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research report on Monday, August 3rd. Canaccord Genuity Group lowered their target price on Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Finally, Bank of America boosted their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research report on Tuesday, July 7th.

Insider Activity

In related news, CEO Charles III sold 17,805 shares of Teladoc Health stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $6.10, for a total value of $108,610.50. Following the sale, the chief executive officer owned 465,535 shares of the company’s stock, valued at approximately $2,839,763.50. This trade represents a 3.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of the company. Renaissance Technologies LLC increased its holdings in Teladoc Health by 1.3% during the first quarter. Renaissance Technologies LLC now owns 8,085,542 shares of the health services provider’s stock worth $44,066,000 after buying an additional 107,400 shares during the last quarter. Jupiter Asset Management Ltd. grew its position in shares of Teladoc Health by 293.9% in the 4th quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock valued at $27,021,000 after acquiring an additional 2,880,008 shares during the period. Monaco Asset Management SAM acquired a new position in shares of Teladoc Health during the 2nd quarter worth about $26,864,000. Pale Fire Capital SE increased its stake in shares of Teladoc Health by 74.8% during the 1st quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider’s stock worth $18,522,000 after purchasing an additional 1,454,288 shares during the last quarter. Finally, Quantinno Capital Management LP raised its holdings in shares of Teladoc Health by 128.0% in the 1st quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock valued at $14,287,000 after purchasing an additional 1,471,631 shares during the period. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Price Performance

TDOC opened at $6.13 on Friday. The company has a market cap of $1.11 billion, a price-to-earnings ratio of -6.19 and a beta of 2.12. The firm has a 50 day simple moving average of $7.03 and a 200 day simple moving average of $6.84. Teladoc Health has a fifty-two week low of $4.40 and a fifty-two week high of $9.89.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business had revenue of $606.93 million during the quarter, compared to the consensus estimate of $615.44 million. During the same quarter in the prior year, the company posted ($0.19) earnings per share. The firm’s revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, analysts expect that Teladoc Health will post -0.92 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company’s offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.